News

Self-management programs benefit adolescent arthritis patients


 

EXPERT ANALYSIS FROM THE CONGRESS OF CLINICAL RHEUMATOLOGY

Dr. Feldman is a member of the data safety monitoring board for Novartis and Bristol-Myers Squibb. He has received research grant support from Baxter and Bayer.

*Correction, 6/18/2013: An earlier version of this story did not include a photo of Dr. Brian Feldman of Ontario, Canada.

Pages

Recommended Reading

Combo may be best rescue therapy for resistant Kawasaki disease
MDedge Rheumatology
Implementing Health Reform: CHIP funding extended
MDedge Rheumatology
Lipids may improve with treatment of juvenile idiopathic arthritis
MDedge Rheumatology
Double-jointed teens have high risk for musculoskeletal pain
MDedge Rheumatology
Cognitive dysfunction, psychosis respond equally in pediatric SLE
MDedge Rheumatology
Push to expand newborn screening for SCID
MDedge Rheumatology
Treat JIA uveitis early, aggressively to avoid vision loss
MDedge Rheumatology
IL-1-beta emerges as key molecule for autoinflammatory diseases
MDedge Rheumatology
Adolescent care transition should begin early
MDedge Rheumatology
New markers, criteria promote earlier intervention in juvenile lupus
MDedge Rheumatology